FLUOXETINE

Course overview

FLUOXETINE IS FDA-APPROVED FOR MAJOR DEPRESSIVE DISORDER (FOR PATIENTS EIGHT YEARS AND OLDER), OBSESSIVE-COMPULSIVE DISORDER, PANIC DISORDER, BULIMIA, BINGE EATING DISORDER, PREMENSTRUAL DYSPHORIC DISORDER, AND BIPOLAR DEPRESSION AS WELL AS TREATMENT-RESISTANT DEPRESSION WHEN USED IN COMBINATION WITH OLANZAPINE. IT ALSO HAS SEVERAL NON-FDA-APPROVED INDICATIONS. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, DOSING, IMPORTANT ADVERSE EFFECTS, CONTRAINDICATIONS, MONITORING, AND TOXICITY OF FLUOXETINE, SO PROVIDERS CAN DIRECT PATIENT THERAPY TO OPTIMAL OUTCOMES IN COMBATING PSYCHOLOGICAL CONDITIONS FOR WHICH IT IS INDICATED.